川崎病冠状动脉异常与BCG部位再激活的川崎病
Rakesh Kumar Pilania1, Abarna Thangaraj2, Sathish Loganathan2
1Pediatric Allergy and Immunology Unit, Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. kumarpilania007@gmail.com.
European journal of pediatrics
|January 19, 2026
概括
在Kawasaki病 (KD) 中BCG位点的再激活是不常见的,主要影响婴儿. 患有KD和BCG部位重新激活的婴儿面临冠状动脉异常的八倍风险,这表明它可以作为风险标志物.
科学领域:
- 儿科 儿科 儿科
- 免疫学 免疫学 免疫学
- 心脏病学 心脏病学
背景情况:
- BCG部位的重新激活是Kawasaki病 (KD) 的公认的临床特征.
- 对于冠状动脉异常 (CAAs) 的BCG位点再激活的预测作用尚不清楚.
- 目前,BCG部位的重新激活并未列入美国心脏协会 (AHA) 关于KD管理的指导方针.
研究的目的:
- 调查卡瓦萨基病患者BCG部位活性化的发生率和临床意义.
- 确定BCG部位的重新激活是否与KD冠状动脉异常 (CAAs) 的风险增加有关.
- 评估BCG部位的活性化作为潜在的床边标记物,用于识别患有KD的高风险婴儿.
主要方法:
- 所有在2009年1月至2024年6月期间入院的KD患者的回顾性审查.
- 对被诊断患有BCG部位再激活的患者的分析.
- 心声图用于评估冠状动脉异常 (CAA).
主要成果:
- 在KD患者中,BCG部位的重新激活发生在1.57% (19/1206).
- 大多数BCG部位再激活的患者是婴儿 (63.2%,12/19).
- 与没有重新激活 (37.2%) 相比,患有KD和BCG部位重新激活的婴儿患CAAs的风险高出八倍 (83.3%).
结论:
- BCG位点的活性化是Kawasaki病的罕见但重要的发现,主要在婴儿中见到.
- BCG部位的重新激活是患有KD的婴儿冠状动脉异常的强有力的预测因素.
- BCG的重新激活可以作为一种有价值的床边标记,用于识别患有严重KD并发症高风险的婴儿.
相关概念视频
01:30Coronary Artery Disease I: Introduction
900
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
900
01:26Coronary Artery Disease II: Pathophysiology
379
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
379
01:27Coronary Artery Disease V: Interprofessional Care
217
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
217
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
814
The methodology to acquire the physiological signal for a Coronary Artery Disease (CAD) test is presented. A method is proposed to interpret the CAD score concerning test positivity and negativity, including the granularities of each. The economics of the test are discussed in the context of the current standard of...
814
01:30Coronary Artery Disease III: Clinical Manifestations
332
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
332
01:26Coronary Artery Disease IV: Preventive Measures
592
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
592